• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肝硬化合并食管静脉曲张出血住院患者再出血相关的预后因素。

Prognostic factors associated with rebleeding in cirrhotic inpatients complicated with esophageal variceal bleeding.

机构信息

Department of Emergency, Changhai Hospital, Second Military Medical School, Shanghai 200433, China.

出版信息

Chin Med J (Engl). 2011 May;124(10):1493-7.

PMID:21740804
Abstract

BACKGROUND

Esophageal variceal bleeding is a frequent and severe complication in patients with cirrhosis. The aim of this study was to identify prognostic factors of esophageal variceal rebleeding in cirrhotic inpatients.

METHODS

Consecutive cirrhotic patients who were admitted to Changhai Hospital because of esophageal variceal bleeding were retrospectively analyzed. To assess the independent factors for recurrent hemorrhage after esophageal variceal bleeding, medical assessment was completed at the time of their initial hospital admission, including documentation of clinical, biochemical, and treatment methods that might contribute to variceal rebleeding. Univariate and multivariate analyses were retrospectively performed.

RESULTS

Totally 186 patients (35.8%) were assigned to a rebleeding group and the other 334 patients (64.2%) to a non-rebleeding group. Multivariate stepwise regression analysis showed that four variables were positively correlated with rebleeding: Child-pugh grade B (OR = 2.664, 95%CI 1.680 - 4.223) (compared with Child-pugh grade A), total bilirubin (Tbil) (OR = 1.0006, 95%CI 1.002 - 1.0107), creatinine (OR = 1.008, 95%CI 1.002 - 1.015) and the cumulative volume of blood transfusion (OR = 1.519, 95%CI 1.345 - 1.716). The presence of ascites (OR = 0.270, 95%CI 0.136 - 0.536) and prophylactic antibiotics (OR = 0.504, 95%CI 0.325 - 0.780) were negatively correlated with rebleeding of the cirrhotic inpatients. According to standardized coefficient, the importance of rebleeding predictors ranked from the most to the least was as follows: the cumulative volume of blood transfusion, Child-pugh grade B, Tbil and creatinine.

CONCLUSION

Rebleeding in cirrhotic inpatients was associated with more blood transfusions, Child-pugh grade B, higher Tbil and creatinine.

摘要

背景

食管胃静脉曲张出血是肝硬化患者常见且严重的并发症。本研究旨在确定肝硬化住院患者食管静脉曲张再出血的预后因素。

方法

回顾性分析因食管胃静脉曲张出血而入住长海医院的连续肝硬化患者。为了评估食管胃静脉曲张出血后再出血的独立因素,在患者初次入院时进行了医学评估,包括记录可能导致静脉曲张再出血的临床、生化和治疗方法。进行了单因素和多因素分析。

结果

共有 186 名患者(35.8%)被分配到再出血组,334 名患者(64.2%)被分配到非再出血组。多因素逐步回归分析显示,有四个变量与再出血呈正相关:Child-pugh 分级 B(OR=2.664,95%CI 1.680-4.223)(与 Child-pugh 分级 A 相比),总胆红素(Tbil)(OR=1.0006,95%CI 1.002-1.0107),肌酐(OR=1.008,95%CI 1.002-1.015)和累计输血量(OR=1.519,95%CI 1.345-1.716)。腹水的存在(OR=0.270,95%CI 0.136-0.536)和预防性使用抗生素(OR=0.504,95%CI 0.325-0.780)与肝硬化患者的再出血呈负相关。根据标准化系数,再出血预测因子的重要性从大到小依次为:累计输血量、Child-pugh 分级 B、Tbil 和肌酐。

结论

肝硬化患者再出血与输血量增加、Child-pugh 分级 B、Tbil 和肌酐升高有关。

相似文献

1
Prognostic factors associated with rebleeding in cirrhotic inpatients complicated with esophageal variceal bleeding.与肝硬化合并食管静脉曲张出血住院患者再出血相关的预后因素。
Chin Med J (Engl). 2011 May;124(10):1493-7.
2
Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices.近年来肝硬化合并食管静脉曲张患者静脉曲张出血的临床意义。
J Gastroenterol Hepatol. 2004 Sep;19(9):1042-51. doi: 10.1111/j.1440-1746.2004.03383.x.
3
Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients.内镜治疗食管静脉曲张出血可改善Child C级肝硬化患者的预后。
J Gastroenterol Hepatol. 2006 Nov;21(11):1704-9. doi: 10.1111/j.1440-1746.2006.04267.x.
4
Independent factors associated with early outcome in Chinese cirrhotic patients after cessation of initial esophageal variceal hemorrhage.与初始食管静脉曲张出血停止后中国肝硬化患者早期结局相关的独立因素。
J Clin Gastroenterol. 2010 Jul;44(6):e123-7. doi: 10.1097/MCG.0b013e3181c3fb22.
5
The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome.氰基丙烯酸酯对胃静脉曲张出血的治疗效果及与临床结局相关的因素。
J Clin Gastroenterol. 2008 Sep;42(8):916-22. doi: 10.1097/MCG.0b013e31811edcd1.
6
[Prognostic factors of early mortality in the 1st episode of hemorrhage caused by esophageal varices].[食管静脉曲张出血首发 episode 早期死亡的预后因素] (注:这里“episode”不太明确准确含义,可结合上下文进一步确定更合适的表述)
Rev Esp Enferm Dig. 1996 Jun;88(6):395-9.
7
Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis.经颈静脉肝内门体分流术(TIPS)后初始门静脉压力梯度降低对肝硬化患者的预后作用
Eur J Gastroenterol Hepatol. 2007 Oct;19(10):846-52. doi: 10.1097/MEG.0b013e3282eeb488.
8
[Comparison of predictive factors related to the mortality and rebleeding caused by variceal bleeding: Child-Pugh score, MELD score, and Rockall score].[与静脉曲张破裂出血所致死亡率和再出血相关的预测因素比较:Child-Pugh评分、MELD评分和Rockall评分]
Taehan Kan Hakhoe Chi. 2002 Dec;8(4):458-64.
9
Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis.肝硬化合并食管或胃静脉曲张出血患者的预后:多因素分析
Hepatobiliary Pancreat Dis Int. 2002 Aug;1(3):416-9.
10
Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.用氰基丙烯酸酯和聚多卡醇或单用聚多卡醇治疗出血性食管静脉曲张:对一组未经选择的肝硬化患者的前瞻性研究结果
Endoscopy. 1997 May;29(4):241-6. doi: 10.1055/s-2007-1004183.

引用本文的文献

1
Acute Variceal Hemorrhage in Germany-A Nationwide Study of 65,357 Hospitalized Cases: Variceal Hemorrhage in Germany.德国急性静脉曲张出血:一项 65357 例住院病例的全国性研究:德国静脉曲张出血。
Can J Gastroenterol Hepatol. 2024 Oct 24;2024:5453294. doi: 10.1155/2024/5453294. eCollection 2024.
2
Risk factors and predictive nomograms for bedside emergency endoscopic treatment following endotracheal intubation in cirrhotic patients with esophagogastric variceal bleeding.肝硬化食管胃静脉曲张出血患者气管插管后床边急诊内镜治疗的危险因素及预测列线图
Sci Rep. 2024 Apr 24;14(1):9467. doi: 10.1038/s41598-024-59802-0.
3
A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage.
一种用于预测内镜治疗食管胃静脉曲张出血后早期再出血的新型列线图。
Dig Dis Sci. 2024 May;69(5):1852-1862. doi: 10.1007/s10620-024-08382-0. Epub 2024 Mar 21.
4
Assessing the Predictive Factors for Bleeding in Esophageal Variceal Disease: A Systematic Review.评估食管静脉曲张疾病出血的预测因素:一项系统评价。
Cureus. 2023 Nov 17;15(11):e48954. doi: 10.7759/cureus.48954. eCollection 2023 Nov.
5
A creatinine-based model for predicting recurrent bleeding after modified percutaneous transhepatic variceal embolization in patients with cirrhosis.一种基于肌酐的模型,用于预测肝硬化患者改良经皮经肝食管静脉曲张栓塞术后再出血情况。
J Interv Med. 2022 Mar 26;5(2):95-102. doi: 10.1016/j.jimed.2022.03.007. eCollection 2022 May.
6
Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding.对胃内有血凝块但无活动性出血或血管病变征象的肝硬化患者进行急诊内镜下静脉曲张结扎术会增加再出血风险。
Clin Mol Hepatol. 2016 Dec;22(4):466-476. doi: 10.3350/cmh.2016.0063. Epub 2016 Dec 25.
7
Risk factors for early rebleeding and mortality in acute variceal hemorrhage.急性静脉曲张出血早期再出血和死亡的危险因素。
World J Gastroenterol. 2014 Dec 21;20(47):17941-8. doi: 10.3748/wjg.v20.i47.17941.